Learning objectives

After watching this webinar, participants will know how to: 

• diagnose and stratify HCM;
• assess the symptomatic HCM patient;
• manage strategies for symptomatic obstructive HCM using current ESC Guidelines in this new era of myosin ATPase inhibitors; and 
• apply small molecule therapy in cardiomyopathies, as well as additional clinical applications including novel drugs. 

Needs assessment and expected educational outcome

To help address the considerable interest in a new class of myosin inhibitors by reviewing management of an agent recently approved by the FDA following a landmark Phase 3 trial (EXPLORER-HCM).

Main topic

• IMAGING

Related topics

• Hypertrophic Cardiomyopathy 

Session information

This webinar is designed for cardiologists working in the field of cardiovascular imaging, and those wishing to update their scientific knowledge on the topic. During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).